The lotion and shampoo versions of Clobex (clobetasol propionate) are available in generic form; however, the spray is still sold as a brand-name drug only. The FDA has determined that the generic medications are equivalent to brand-name Clobex. However, the generic versions may have different inactive ingredients, which may cause problems for some people.
Clobex® (clobetasol propionate) is a prescription skin medication. It is a topical steroid (a steroid that is applied to the skin) that is applied once or twice a day. It comes in the form of lotion, spray, and shampoo.
Clobex shampoo and lotion are made by DPT Laboratories, Ltd., for Galderma Laboratories, L.P. They are also both available in generic form. Clobex spray is made by CPL for Galderma Laboratories, L.P. The spray is protected against generic competition by patents, and no generic versions are available in the United States.
Generic Clobex is available in the following strengths and forms:
- Clobetasol propionate 0.05% lotion
- Clobetasol propionate 0.05% shampoo.
Generic Clobex is sold by various manufacturers, such as Actavis Mid Atlantic, LLC, and Sandoz, Inc.
The first patents for Clobex spray are currently set to expire in February 2018. This is the earliest predictable date a generic version could become available. However, other circumstances could come up to extend or shorten the exclusivity period. This could include such things as other patents for specific Clobex uses or lawsuits.